A study of 702 patients with biopsy proven NAFLD and 310 healthy controls from Italy and the UK found that the Lys121Gln ENPP1/PC1 and IRS-1 972Arg polymorphisms affecting insulin receptor activity predisposed patients with diabetes to liver damage and decreased hepatic insulin [116]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.